The human papillomavirus (HPV), a common sexually transmitted infection, accounts for 70% of all throat cancers, according to the National Cancer Institute.
Resilience allocates $225M to expand manufacturing capacity in Cincinnati
National Resilience is working to expand its clinical and commercial drug manufacturing capabilities to provide more than 200 million units to its clients by 2025.